T1	Participants 136 242	One hundred twenty-two chemotherapy-naive patients with histologically confirmed colorectal adenocarcinoma
T2	Participants 857 898	Patients who received CDDP/FU experienced
T3	Participants 954 1147	grades 3 and 4 hematologic toxicity occurred in 22% and 0% of patients, respectively (P = .0001); grades 2 to 4 nausea and vomiting occurred in 80% and 15% of patients, respectively (P = .0001)
